Clavis Pharma ASA (OSE: CLAVIS) releases the company's first quarter 2010 results on Thursday 29 April 2010 at Hotel Continental, Stortingsgaten 24/26, Oslo, Norway.
The presentation will start at 08:30 (CET).
Following the presentation, there will be a Q&A session. Breakfast will be served from 08:00 hours (CET). Clavis Pharma welcomes all interested parties.
The quarterly report and presentation will be available at the Oslo Stock Exchange http://www.newsweb.no
Contact
Olav Hellebø, CEO
Office: +47 24 11 09 65 / Mobile: +44 783 390 4901
E-mail: olav.hellebo@clavispharma.com
Gunnar Manum, CFO
Office: +47 24 11 09 71 / Mobile: +47 95 17 91 90
E-mail: gunnar.manum@clavispharma.com
For international press enquiries:
Mark Swallow / Nina Enegren / David Dible
Citigate Dewe Rogerson
Office: +44 207 282 2948
E-mail: clavispharma@citigatedr.co.uk / mark.swallow@citigatedr.co.uk
Disclaimer
This news release contains forward-looking statements and forecasts based on uncertainty, since they relate to events and
depend on circumstances that will occur in the future and which, by their nature, will have an impact on results of operations
and the financial condition of Clavis Pharma. There are a number of factors that could cause actual results and developments
to differ materially from those expressed or implied by these forward-looking statements. These factors include, among other
things, risks associated with technological development, the risk that research & development will not yield new products
that achieve commercial success, the impact of competition, the ability to close viable and profitable business deals, the
risk of non-approval of patents not yet granted and difficulties of obtaining relevant governmental approvals for new products.
No expressed or implied representations or warranties are given concerning Clavis Pharma or the accuracy or completeness of the information provided herein, and no claims shall be made by the recipient hereof by virtue of this News Announcement or the information contained herein.
Clavis Pharma(TM) is a registered trademark of Clavis Pharma ASA.